172 related articles for article (PubMed ID: 11915012)
1. Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans.
Rubin MA; Carroll KC; Cahill BC
Clin Infect Dis; 2002 Apr; 34(8):1160-1. PubMed ID: 11915012
[No Abstract] [Full Text] [Related]
2. Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole.
Safdar A
Clin Infect Dis; 2002 May; 34(10):1415-7. PubMed ID: 11981740
[TBL] [Abstract][Full Text] [Related]
3. New antifungal agents-treatment standards are beginning to grow old.
Maschmeyer G
J Antimicrob Chemother; 2002 Feb; 49(2):239-41. PubMed ID: 11815563
[No Abstract] [Full Text] [Related]
4. Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin.
Cooke FJ; Terpos E; Boyle J; Rahemtulla A; Rogers TR
Clin Microbiol Infect; 2003 Dec; 9(12):1238-41. PubMed ID: 14686991
[TBL] [Abstract][Full Text] [Related]
5. New type of antifungal approved for invasive aspergillosis.
Thompson CA
Am J Health Syst Pharm; 2001 Apr; 58(7):558, 560. PubMed ID: 11296601
[No Abstract] [Full Text] [Related]
6. Caspofungin (Cancidas) for aspergillosis.
Med Lett Drugs Ther; 2001 Jul; 43(1108):58-9. PubMed ID: 11445777
[No Abstract] [Full Text] [Related]
7. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent.
Koss T; Bagheri B; Zeana C; Romagnoli MF; Grossman ME
J Am Acad Dermatol; 2002 Jun; 46(6):945-7. PubMed ID: 12063497
[TBL] [Abstract][Full Text] [Related]
8. Caspofungin.
Deresinski SC; Stevens DA
Clin Infect Dis; 2003 Jun; 36(11):1445-57. PubMed ID: 12766841
[TBL] [Abstract][Full Text] [Related]
9. Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
Kartsonis NA; Saah AJ; Joy Lipka C; Taylor AF; Sable CA
J Infect; 2005 Apr; 50(3):196-205. PubMed ID: 15780413
[TBL] [Abstract][Full Text] [Related]
10. Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis.
Maertens J
Int J Antimicrob Agents; 2006 Jun; 27(6):457-67. PubMed ID: 16701980
[TBL] [Abstract][Full Text] [Related]
11. Comment: caspofungin acetate for treatment of invasive fungal infections.
Grau S; Mateu-De Antonio J
Ann Pharmacother; 2003 Dec; 37(12):1919. PubMed ID: 14632549
[No Abstract] [Full Text] [Related]
12. New drug fights invasive fungal infection.
FDA Consum; 2001; 35(3):5. PubMed ID: 11458553
[No Abstract] [Full Text] [Related]
13. Caspofungin in combination with itraconazole and amphotericin B for the treatment of invasive Aspergillosis in humans, with a method to test ex vivo synergism.
Tascini C; Tagliaferri E; Iapoce R; Leonildi A; Menichetti F
Clin Microbiol Infect; 2003 Aug; 9(8):901-2. PubMed ID: 14616718
[No Abstract] [Full Text] [Related]
14. [First echinocandin on the market. New type of antifungal against Aspergillus & Co].
MMW Fortschr Med; 2002 Apr; 144 Suppl 1():83-4. PubMed ID: 12043093
[No Abstract] [Full Text] [Related]
15. Successful treatment of subcutaneously disseminated aspergillosis with caspofungin acetate in an allogeneic peripheral blood stem cell transplantation patient.
Chamuleau ME; Deenik W; Zweegman S; Jonkhoff AR; Zaaijer HL; Janssen JJ
Haematologica; 2003 Apr; 88(4):ECR10. PubMed ID: 12681983
[TBL] [Abstract][Full Text] [Related]
16. The first echinocandin: caspofungin.
Cornely OA; Schmitz K; Aisenbrey S
Mycoses; 2002; 45 Suppl 3():56-60. PubMed ID: 12690973
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies.
Kontoyiannis DP; Hachem R; Lewis RE; Rivero GA; Torres HA; Thornby J; Champlin R; Kantarjian H; Bodey GP; Raad II
Cancer; 2003 Jul; 98(2):292-9. PubMed ID: 12872348
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
19. [Invasive aspergillosis: clinical manifestations and treatment].
Lumbreras C; Gavaldá J
Rev Iberoam Micol; 2003 Sep; 20(3):79-89. PubMed ID: 15456363
[TBL] [Abstract][Full Text] [Related]
20. CNS-aspergillosis: are there new treatment options?
Schwartz S; Thiel E
Mycoses; 2003; 46 Suppl 2():8-14. PubMed ID: 15055138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
